Satish Mehta and Family

Emcure Pharmaceuticals is one of India's more internationally diversified pharmaceutical exporters. It became more publicly known when Namita Thapar joined Shark Tank.

Satish Mehta founded Emcure Pharmaceuticals in 1981 and has built it into one of India's more internationally diversified pharmaceutical companies, with revenues exceeding Rs 7,800 crore and operations exporting medicines to over 70 countries. The company's therapeutic focus spans biologics, oncology, HIV treatment and women's health, a range that reflects sustained investment in manufacturing capabilities for complex and regulated drug categories rather than the mass-market generics that dominate many Indian pharma portfolios.

The next generation has assumed significant operational responsibility. Namita Thapar leads the Indian business, Samit Mehta oversees international operations and Siddharth Mehta manages specific business lines. Namita Thapar has also become prominent beyond the pharmaceutical industry as an investor on Shark Tank India, a visibility that has made Emcure's brand more recognisable to a general consumer audience than most pharmaceutical companies achieve. That broader public profile is commercially useful for a company that has historically operated in the less visible prescription drugs segment of the market.